HomeVYNE • NASDAQ
add
Vyne Therapeutics Inc
Previous close
$2.47
Day range
$2.42 - $2.58
Year range
$1.67 - $8.73
Market cap
35.25M USD
Avg Volume
137.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 76.00K | 1,166.67% |
Operating expense | 6.91M | -13.54% |
Net income | -6.19M | 37.78% |
Net profit margin | -8.14K | 95.09% |
Earnings per share | — | — |
EBITDA | -6.81M | 14.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 93.25M | 201.71% |
Total assets | 97.68M | 139.67% |
Total liabilities | 8.95M | -4.23% |
Total equity | 88.74M | — |
Shares outstanding | 14.10M | — |
Price to book | 0.39 | — |
Return on assets | -29.21% | — |
Return on capital | -34.01% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -6.19M | 37.78% |
Cash from operations | -5.14M | -6.78% |
Cash from investing | -62.35M | -6,235,500.00% |
Cash from financing | 82.66M | 39,641.83% |
Net change in cash | 15.17M | 429.68% |
Free cash flow | -3.23M | -702.23% |
About
Founded
2003
Headquarters
Website
Employees
10